Crossject Share Price
Stocks
ALCJ
FR0011716265
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Euronext Paris
09:25:00 24/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1.330 EUR | +1.37% |
|
+0.91% | -39.27% |
| 23/09 | CROSSJECT Aligns ZEPIZURE Pediatric Development Plan With BARDA And FDA | CI |
| 26/05 | Crossject: The last round of financing? | AL |
| Market Cap | 7.24Cr 8.23Cr 6.83Cr 6.23Cr 12Cr 790.23Cr 12Cr 82Cr 32Cr 402.18Cr 31Cr 30Cr 1.31TCr | P/E 2026 * |
3.24x | P/E 2027 * | 2.56x |
|---|---|---|---|---|---|
| Enterprise Value | 5.45Cr 6.2Cr 5.14Cr 4.69Cr 8.77Cr 594.88Cr 8.84Cr 62Cr 24Cr 302.76Cr 23Cr 23Cr 985.22Cr | EV / Sales 2026 * |
0.9x | EV / Sales 2027 * | 0.39x |
| Free-Float |
92.46% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALCJ | Real-time | |
CBOE
| Real-time | ||
|
Börse Stuttgart
| 74C | Delayed | |
|
Boerse Muenchen
| 74C | Real-time | |
|
Deutsche Boerse AG
| 74C | Delayed | |
|
Tradegate
| 74C | Real-time | |
|
CBOE
| Real-time |
| 1 day | +1.37% | ||
| 1 week | +0.91% | ||
| Current month | -13.75% | ||
| 1 month | -6.99% | ||
| 3 months | -28.49% | ||
| 6 months | -34.80% | ||
| Current year | -39.27% |
| 1 week | 1.3 |  | 1.37 |
| 1 month | 1.19 | | 1.72 |
| Current year | 1.19 | | 2.58 |
| 1 year | 1.19 | | 2.7 |
| 3 years | 0.72 | | 5.96 |
| 5 years | 0.72 | | 5.96 |
| 10 years | 0.72 | | 7.57 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 08/08/2001 | |
Lionel Seltz
DFI | Director of Finance/CFO | - | 25/03/2026 |
Tony C. Tipton
PRN | Corporate Officer/Principal | - | 20/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Philippe Monnot
CHM | Chairman | 67 | 26/06/2009 |
Eric Nemeth
BRD | Director/Board Member | 67 | - |
| Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/07/25 | Buy | Director | 13,386 | 0.0266% | ||
| 01/07/25 | Buy | Director | 50 | 0.0001% | ||
| 01/07/25 | Buy | Director | 337 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.37% | +0.91% | -19.69% | -65.45% | 8.14Cr | |
| +7.82% | +1.37% | +163.56% | +454.21% | 11Cr | |
| -1.81% | -5.15% | -24.50% | -46.61% | 9.97Cr | |
| +3.07% | -2.89% | +40.00% | +26.32% | 7.36Cr | |
| Average | +2.61% | -1.32% | +39.84% | +92.11% | 9.02Cr | |
| Weighted average by Cap. | +2.73% | -1.88% | +45.02% | +111.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.08Cr 6.91Cr 5.73Cr 5.23Cr 9.78Cr 663.52Cr 9.86Cr 69Cr 27Cr 337.7Cr 26Cr 25Cr 1.1TCr | 6.52Cr 7.41Cr 6.15Cr 5.61Cr 10Cr 711.54Cr 11Cr 74Cr 29Cr 362.13Cr 28Cr 27Cr 1.18TCr |
| Net income | 2.83Cr 3.22Cr 2.67Cr 2.43Cr 4.55Cr 308.84Cr 4.59Cr 32Cr 12Cr 157.18Cr 12Cr 12Cr 511.49Cr | 3.56Cr 4.05Cr 3.36Cr 3.06Cr 5.73Cr 388.51Cr 5.77Cr 40Cr 16Cr 197.73Cr 15Cr 15Cr 643.43Cr |
| Net Debt | -1.79Cr -2.04Cr -1.69Cr -1.54Cr -2.88Cr -195.35Cr -2.9Cr -20Cr -7.85Cr -99Cr -7.64Cr -7.47Cr -323.52Cr | -4.7Cr -5.34Cr -4.43Cr -4.04Cr -7.56Cr -512.92Cr -7.62Cr -53Cr -21Cr -261.05Cr -20Cr -20Cr -849.48Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | €1.330 | +1.37% | 2,03,577 |
| 23/26/23 | €1.312 | -2.81% | 63,053 |
| 22/26/22 | €1.350 | +1.05% | 1,32,686 |
| 21/26/21 | €1.336 | +0.75% | 1,24,750 |
| 18/26/18 | €1.326 | +0.61% | 2,15,049 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALCJ Stock
Select your edition
All financial news and data tailored to specific country editions
